262 related articles for article (PubMed ID: 2788173)
1. Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.
Oster W; Cicco NA; Klein H; Hirano T; Kishimoto T; Lindemann A; Mertelsmann RH; Herrmann F
J Clin Invest; 1989 Aug; 84(2):451-7. PubMed ID: 2788173
[TBL] [Abstract][Full Text] [Related]
2. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
3. Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.
Brach MA; Gruss HJ; Asano Y; de Vos S; Ludwig WD; Mertelsmann R; Herrmann F
Cancer Res; 1992 Apr; 52(8):2197-201. PubMed ID: 1373106
[TBL] [Abstract][Full Text] [Related]
4. Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1 beta in the autonomous growth of acute myeloblastic leukaemia cells--studies using purified CD34-positive cells.
Bradbury D; Rogers S; Reilly IA; Kozlowski R; Russell NH
Leukemia; 1992 Jun; 6(6):562-6. PubMed ID: 1376378
[TBL] [Abstract][Full Text] [Related]
5. Control of blast cell proliferation and differentiation in acute myelogenous leukemia by soluble polypeptide growth factors.
Herrmann F; Oster W; Mertelsmann R
Klin Padiatr; 1990; 202(4):212-7. PubMed ID: 2203937
[TBL] [Abstract][Full Text] [Related]
6. Role of colony-stimulating factors in the biology of acute myelogenous leukemia.
Oster W; Mertelsmann R; Herrmann F
Int J Cell Cloning; 1989 Jan; 7(1):13-29. PubMed ID: 2645373
[TBL] [Abstract][Full Text] [Related]
7. Growth potentiating activity of endogenous production of interleukin-1 and tumor necrosis factor alpha in blast cells of acute myeloblastic leukemia.
Murohashi I; Tohda S; Imai Y; Hirai Y; Nara N
Exp Hematol; 1993 Jul; 21(7):846-51. PubMed ID: 8319777
[TBL] [Abstract][Full Text] [Related]
8. [The role of cytokines in the proliferation of leukemia cells in acute myelogenous leukemia].
Nara N
Rinsho Byori; 1993 Dec; 41(12):1289-95. PubMed ID: 7507532
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 production by the blast cells of acute myeloblastic leukemia: regulation by endogenous interleukin-1 and biological implications.
Beauchemin V; Villeneuve L; Rodriguez-Cimadevilla JC; Rajotte D; Kenney JS; Clark SC; Hoang T
J Cell Physiol; 1991 Sep; 148(3):353-61. PubMed ID: 1918169
[TBL] [Abstract][Full Text] [Related]
10. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
Kerangueven F; Sempere C; Tabilio A; Mannoni P
Eur Cytokine Netw; 1990; 1(2):99-107. PubMed ID: 2129395
[TBL] [Abstract][Full Text] [Related]
11. Different types of human leukemias express the message for TNF-alpha and interleukin-10.
Schulz U; Munker R; Ertl B; Holler E; Kolb HJ
Eur J Med Res; 2001 Aug; 6(8):359-63. PubMed ID: 11549518
[TBL] [Abstract][Full Text] [Related]
12. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.
Rogers SY; Bradbury D; Kozlowski R; Russell NH
Exp Hematol; 1994 Jul; 22(7):593-8. PubMed ID: 7516889
[TBL] [Abstract][Full Text] [Related]
13. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M
Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of growth factor expression in acute myeloid leukemia (AML).
Fiedler W; Suciu E; Wittlief C; Ostertag W; Hossfeld DK
Leukemia; 1990 Jul; 4(7):459-61. PubMed ID: 2197515
[TBL] [Abstract][Full Text] [Related]
16. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
[TBL] [Abstract][Full Text] [Related]
18. Role of suramin as an IL-1 inhibitor in suppression of acute myelogenous leukemia progenitor proliferation.
Estrov Z; Talpaz M; Estey EH; Strassmann G
Exp Hematol; 1995 Sep; 23(10):1080-7. PubMed ID: 7544738
[TBL] [Abstract][Full Text] [Related]
19. Effect of granulocyte-macrophage colony-stimulating growth factor on interferon and tumor necrosis factor production in whole blood cell cultures of patients with acute myelogenous leukemia.
Kamińska T; Hus I; Dmoszyńska A; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 2():S83-7. PubMed ID: 11665752
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
